Suzhou CellPro Biotechnology Co., Ltd.
PrivateLast Round
Series B
Sep 18, 2022
Company Overview
Suzhou CellPro Biotechnology Co., Ltd. is a life science company that develops, manufactures, and sells high-end biomedical plastic consumables for molecular diagnosis, cell culture, and immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou CellPro Biotechnology Co., Ltd. Comparables
Compare Suzhou CellPro Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wuxi NEST Biotechnology Co., Ltd. | 89% | |
| Zhejiang Sorfa Life Science Research Co., Ltd. | 87% | |
| Yongyue Medical Technology (Kunshan) Co., Ltd. | 87% | |
Suzhou CellPro Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 18, 2022 | ||||
| Series A Extension | Mar 30, 2022 | ||||
| Series A | Aug 1, 2021 | ||||
| Angel | Feb 1, 2020 |
Suzhou CellPro Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 顺融资本 | Series A, Series A Extension, Series B |
| Oriza Holdings | Series A, Series A Extension, Series B |
| YuanBio Venture Capital | Series B |
| CICC Capital | Series B |
| Sunshine Insurance Group | Series A Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2022
Led by CICC Capital and YuanBio Venture Capital.
- Mar 30, 2022
Raised Series A Extension with Oriza Holdings and Sunshine Insurance Group.
Suzhou CellPro Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Suzhou CellPro Biotechnology Co., Ltd.'s valuation, stock price, and market status.